Precision Medicine Initiative

The multi-disciplinary health initiative aims to sequence over 100,000 patients' genomes by 2023 as part of its Mosaic Project.  

For the two five year grants, the NIH will favor applicants with experience providing counseling throughout the US and to diverse and disadvantaged communities.  

The centers will generate genomic data from biosamples contributed by participants in the program and analyze data that will be returned to them.

Eric Green, NHGRI director

Fifteen years after the Human Genome Project was declared completed, genomic medicine is beginning to be implemented, sooner than Green and others had expected.

During a webcast to discuss the recent funding announcement for genome centers, project organizers offered details on data generation and return of results.

The All of Us Participant Technology Systems Center offers web and mobile apps to aggregate data and engage patients who join the All of Us cohort program.

Although people have greater access to personalized drugs and tests than ever before, a survey by GenomeWeb and the PMC shows public awareness isn't improving.  

Ahead of the national launch, 44,000 early participants signed up for the program during a beta phase, and 26,000 people have completed the enrollment process.

Trump has repeatedly threatened to drastically slash NIH funding, but its new $37 billion budget is a historic high.

Applicants will be expected to develop the capacity to conduct up to 200,000 genome-wide assays per year and generate high-quality genotyping and genome sequence data.

Pages

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.